The aim of this study is to investigate the validity and reliability of the 6 Minutes Pegboard and Ring Test (6PBRT) in patients with Interstitial Lung Disease (ILD).
Eligibility
Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria:
* who were diagnosed with ILD according to the ATS/ERS/JRS/ALAT guidelines,
* were over 18 years of age,
* had not changed their treatment for the last 3 months,
* had a stable clinical status for the last 3 months.
Exclusion Criteria:
* Neurological comorbidity,
* Orthopedic comorbidity that impairs upper extremity function,
* Kyphoscoliosis and/or severe postural abnormalities,
* Uncontrolled cardiac problems,
* Uncontrolled diagnosis of Diabetes Mellitus,
* Ischemic heart disease,
* Newly diagnosed history of cancer,
* Diagnosis of obstructive pulmonary disease,
* Cognitive impairments such as Alzheimer's or dementia,
* Use of immunosuppressive medications (excluding corticosteroids),
* History of recent surgery,
* Refusal to answer questions,
* Refusal to participate voluntarily.
Primary outcome measure(s)
6 Minutes Pegboard and Ring Test (6PBRT) — Day 1 The 6-Minute Pegboard and Ring Test (6PBRT) is designed to assess upper extremity functional capacity using unsupported arm movements. The setup includes four horizontally aligned bars: two at shoulder height and two positioned 20 cm above. Participants, seated with back support, sequentially transfer rings between the bars for six minutes, and the total number of rings moved serves as the performance score.
6 Minutes Walking Tests (6MWT) — Day 1 Total distance walked (in meters) during the 6MWT will be recorded. Higher distance reflects improved functional capacity.
Unsupported Upper-Limb Exercise Test (UULEX) — Day 1 Patients will be instructed to lift five bars consecutively and rhythmically until the onset of fatigue. The bars will have incremental weights of 200 g, 500 g, 1 kg, and 2 kg, respectively. The duration of the activity will be recorded to assess the patients' endurance levels.
Trial sites (1)
Facility
City
Region
Status
Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.